Industry Category
Business Keywords
Company Description
ImageneBio is a dynamic biotechnology company focused on developing innovative therapeutics for immunological, autoimmune, and inflammatory diseases. ImageneBio is committed to improving patient outcomes through cutting-edge research and development. Located at 12526 High Bluff Drive, Suite 345, San Diego, CA 92130, US, ImageneBio is dedicated to advancing clinical solutions in the biotechnology sector.
The company's lead asset, IMG-007, a nondepleting anti-OX40 monoclonal antibody, has completed clinical trials in atopic dermatitis and alopecia areata. ImageneBio is now conducting a Phase 2b clinical trial of IMG-007 for patients with moderate-to-severe atopic dermatitis, showcasing their commitment to addressing critical medical needs.
ImageneBio continues to expand its research and development efforts, striving to deliver differentiated clinical profiles in the I&I space. Explore the opportunities with ImageneBio and be part of the future of biotechnology. We invite the management team at ImageneBio to create a customized and exclusive company showcase and product listing on our platform.
ImageneBio est une entreprise de biotechnologie dynamique axée sur le développement de thérapies innovantes pour les maladies immunologiques, auto-immunes et inflammatoires. ImageneBio s'engage à améliorer les résultats pour les patients grâce à la recherche et au développement de pointe. Située au 12526 High Bluff Drive, Suite 345, San Diego, CA 92130, États-Unis, ImageneBio se consacre à l'avancement des solutions cliniques dans le secteur de la biotechnologie.
L'actif principal de la société, IMG-007, un anticorps monoclonal anti-OX40 non déplétant, a terminé les essais cliniques sur la dermatite atopique et l'alopécie areata. ImageneBio mène actuellement un essai clinique de phase 2b de l'IMG-007 pour les patients atteints de dermatite atopique modérée à sévère, ce qui témoigne de son engagement à répondre aux besoins médicaux essentiels.
ImageneBio continue d'étendre ses efforts de recherche et de développement, s'efforçant de fournir des profils cliniques différenciés dans l'espace I&I. Explorez les opportunités avec ImageneBio et faites partie de l'avenir de la biotechnologie. Nous invitons l'équipe de direction d'ImageneBio à créer une vitrine d'entreprise et une liste de produits personnalisées et exclusives sur notre plateforme.
Key Personnel / Employees
Compare Companies Side by Side
Compare ImageneBio with 3 companies in Biotechnology-Research
| Comparison Field |
ImageneBioMain Company |
Facet BiotechView Profile |
LEO Foundation Skin...View Profile |
Qu Biologics Inc.View Profile |
|---|---|---|---|---|
|
Founded Year
|
— | 2008 | 2019 | 2007 |
|
Company Size
|
— | 51-200 | 51-200 | 11-50 |
|
City
|
San Diego, CA | Copenhagen, Capital Region | Burnaby, British Columbia | |
|
Country
|
United States | Denmark | Canada | |
|
Skills & Keywords
Comparing with main company
|
12 Total Skills
Biotechnology
Immunology
Autoimmune Diseases
Inflammatory Diseases
Therapeutics
Monoclonal Antibody
Clinical Trials
I&I
immunology
OX40
inflammation
biotechnology
|
2 Total
2 Unique
Unique Skills:
antibody engineering
oncology
|
4 Total
4 Unique
Unique Skills:
allergic contact dermatitis
atopic dermatitis
psoriasis
skin
|
18 Total
18 Unique
Unique Skills:
arthritis
autoimmune diseases
autoimmune disorders
biologics
biotech
cancer
+12
|
4
Total Companies2007
Oldest Founded3
Countries36
Unique SkillsSimilar Companies
Other organizations in the same industry
Cerapedics Inc.
Biotechnology-ResearchCerapedics is an Orthopedics company aspiring to redefine the standard of care for bone repair.
Alternative Company Names
This company is also known as